Rapid Access Carotid Endarterectomy can be Performed in the Hyperacute Period without a Significant Increase in Procedural Risks  by Salem, M.K. et al.
Eur J Vasc Endovasc Surg (2011) 41, 222e228Rapid Access Carotid Endarterectomy can be
Performed in the Hyperacute Period without
a Significant Increase in Procedural RisksM.K. Salem a,*, R.D. Sayers a, M.J. Bown a, D.J. Eveson b, T.G. Robinson b,
A.R. Naylor aaVascular Surgery Group, Department of Cardiovascular Sciences, Robert Kilpatrick Clinical Sciences Building,
University of Leicester, Leicester LE2 7LX, UK
bAgeing and Stroke Medicine, Department of Cardiovascular Sciences, University of Leicester, Leicester LE2 7LX, UK
Submitted 19 August 2010; accepted 27 October 2010
Available online 3 December 2010KEYWORDS
Carotid stenosis;
Fast track;
Carotid
endarterectomy;
Stroke;
TIATo access continuing medical
* Corresponding author. Tel.: þ44 1
E-mail address: ms447@le.ac.uk (M
1078-5884/$36 ª 2010 European Socie
doi:10.1016/j.ejvs.2010.10.017Abstract Objectives: The highest risk of recurrent stroke after suffering a transient ischae-
mic attack (TIA) or minor stroke is during the first 7e14 days. Contemporary guidelines recom-
mend that carotid endarterectomy (CEA) should be performed within this time period, but
there are concerns regarding (1) how this can be achieved logistically and (2) whether this
policy is associated with a significant increase in procedural risks.
Design: This is a prospective, consecutive study of delays to surgery and 30-day outcomes in
recently symptomatic patients who underwent CEA between 1 October 2008 and 15 June
2010 after the creation of a rapid access TIA service.
Results: A total of 109 symptomatic patients underwent CEA, 78% within 14 days of the index
event and 90% within 14 days of referral. The median delay to surgery was 9 days from the
index event and 4 days from referral. There were no perioperative deaths. Two strokes
occurred (one intra-operative and one post-operative) to give a 30-day death/stroke rate of
1.83%. Patients undergoing CEA within 14 days of the index event incurred a death/stroke rate
of 2.4% (2/84), increasing to 4.3% in patients undergoing surgery within 7 days (2/47).
Conclusion: Service reconfigurations can lead to significant reductions in delays to treatment
in patients with symptomatic carotid disease. CEA can be performed in the hyperacute period
without significantly increasing the operative risk.
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risk of stroke after suffering a transient ischaemic attack
(TIA)/minor stroke is during the first 7e14 days.1 In addition,
pooled data from the European Carotid Surgery Trial (ECST),
the North American Symptomatic Carotid Endarterectomy
Trial (NASCET) and Veterans Affairs (VA) trials suggest that
patients undergoing expedited carotid endarterectomy
(CEA) gained greater benefit than patients with significant
delays to surgery.2 Performing CEAwithin 2weeks in patients
with a NASCET 50e99% stenosis (ECST 70e99%) will prevent
185 ipsilateral strokes at 5 years per 1000 CEAs, while only
eight strokes will be prevented at 5 years, if surgery is
delayed by >12 weeks.3,4 Accordingly, guidelines from the
European Vascular Surgery Society5 and the UK National
Institute for Clinical Excellence (NICE)6 now recommend that
CEA shouldbeperformedwithin 14days of onset of symptoms
unless contraindicated. The UK National Stroke Strategy,7
however, recommends that CEA should be regarded as an
emergency procedure and should be performed within 48 h
of TIA orminor stroke. However, despite evidence suggesting
that there is considerable benefit in intervening early, there
are concerns about the logistics of how a 48-h or 14-day
target can be met and whether expedited CEA is associated
with a significant increase in the procedural risk. Urgent CEA
is still considered by many surgeons to significantly increase
the procedural risk,8,9 possibly to the extent that any benefit
(in terms of late-stroke prevention) may be negated.
Inanearlier study,10 thisunit showed thata surgeonwithan
interest in carotid surgery could not make simple modifica-
tions topractice (useofad-hoc cancelled theatre sessions,ad-
hoc cancellation of non-urgent cases and altering the way
referrals were processed) and then expect to radically reduce
delays to surgery.Theprevious studyconcluded that this could
only be achieved by a radical reorganisation of practice
amongst stroke physicians, hospital managers and surgeons.
This article reviews the effect of introducing a new rapid
access carotid surgery service with specific regard to delays
to surgery and any effect on the procedural risk.
Materials and methods
In the past, patients with symptomatic carotid disease were
referred to the Vascular Surgery Unit by their family doctor,
local/regional stroke physicians, Accident and Emergency
Department or Eye Casualty. In a review of practice, it was
noted that therewere amultitude of reasonswhy delayswere
introduced into the system. These included lack of patient
awareness, no rapid access TIA clinic, limited single visit
imaging (i.e., computed tomography (CT) and duplex ultra-
sound), administrative referral delays, no prioritisation on
waiting lists and a reluctance for surgeons to ask colleagues to
take on CEA patients to expedite their operation.10
In October 2008, a complete service reconfiguration took
place, which is summarised below.
Rapid access TIA clinic
All patients with a suspected TIA/minor stroke attended
their family doctor or Accident and Emergency Department
and had a referral faxed to the TIA clinic where this was
rapidly triaged. Any patient with an ABCD2 score of 0e3werescheduled to be seen in the neurovascular clinic within 7
days. However, any patient with an ABCD2 score of 4e7 was
seen either the same day or the following morning. Risk
factor modification was commenced in the TIA clinic, where
duplex ultrasound and either CTor magnetic resonance (MR)
brain imagingwas also performed.Optimummedical therapy
(anti-platelet, anti-hypertensive, anti-arrhythmic, statin
therapy, etc.) was commenced in the TIA clinic. Any patient
with a NASCET 50e99% stenosis was then discussed with the
on-call vascular surgeon and immediately transferred to the
Leicester Vascular Surgery Unit unless there were contrain-
dications such as severe co-morbidity, dementia or advanced
malignancy.
Vascular surgery unit
Following transfer, all patients underwent a second duplex
assessment (in linewithHealthTechnologyAssessment (HTA)
guidelines)11 and also underwent a 30-min transcranial
Doppler (TCD) recording to identify those with spontaneous
embolisation (i.e., those with an unstable carotid plaque).
Patients with uncontrolled hypertension started treatment
as soon as possible with the aim of getting the systolic blood
pressure (BP) below160mmHg,wherever possible. It was the
aim of the service to only delay CEA if the hypertension did
not respond to treatment and remained excessively high
(>190 mmHg systolic BP).
The unit also aimed to offer expedited CEA to all patients,
whopresentedwith aminor stroke provided they fulfilled the
following criteria: Rankin score 0e2, no internal carotid
artery (ICA) occlusion, no evidence of haemorrhage on CT/
MRI, infarction <1/3 of the middle cerebral artery (MCA)
territory and patient not obtunded. Patients with a Rankin
score 3 only underwent urgent CEA, if they had recurrent
symptoms while in hospital and, even so, only after discus-
sion with the stroke physicians and anaesthetists.
The Vascular Surgery Unit maintains 2 half-day operating
lists (Tuesday/Friday) for performing expedited CEA. CEA
procedures were performed by the consultant allocated to
that particular list (i.e., this could be different to the
consultant admitting the patient). The emergency theatre
was only used if these lists were already filled. All patients
received 300 mg aspirin and 40 mg simvastatin in the TIA
clinic, in addition to other appropriate secondary preven-
tion therapy, and these were then continued throughout
the preoperative period, although the aspirin dose was
reduced to 75 mg. All patients received 75 mg clopidogrel
the night before surgery, in addition to their regular aspirin.
CEA
The CEA procedure has remained essentially unchanged
since 1991 (general anaesthesia, routine patching, routine
shunting, systemic heparinisation (unfractionated) and
distal intimal tacking sutures).12 A preliminary clamp of the
internal carotid artery is performed to minimise embolic
events duringmanipulation of the carotid bifurcation if there
is evidence of spontaneous embolisation (SE) during the
dissection phase. TCD monitoring was undertaken following
induction of general anaesthesia using a fixed 2-MHz head
probe and continued throughout the procedure. Completion
224 M.K. Salem et al.angioscopy was performed with a flexible hysteroscope
(Olympus 1070-48). Unit policy was to repair all intimal flaps
>3 mm and aspirate any residual thrombi from the lumen.
Prior to August 2006, all patients underwent 3 h of TCD
monitoring after CEA and any patient with a high rate of
embolisation was given incremental dose intravenous
dextran.13 After August 2006, all patients received 75 mg
clopidogrel the night before surgery (in addition to routine
aspirin). Only two patients (out of 420 patients) have required
post-operative dextran and routine post-operative TCD
monitoring has now ceased.14
Following surgery, the patient was nursed in theatre
recovery for 3 h and then transferred back to the vascular
ward, pending discharge on day 2. There were written
guidelines for managing hypertension in the post-operative
period.15
Procedural complications
Thirty-day outcomes included any stroke (ipsilateral and
contralateral hemisphere), myocardial infarction (MI) or
death within 30 days of the procedure. Stroke was defined as
any new (or worsened) focal neurological deficit lasting for
more than 24 h. All patients received a routine neurological
examination at 30 days by a consultant stroke physician. Any
patient suspected of having suffered a procedural stroke
underwent a CT scan, extracranial duplex ultrasound exam-
ination and intracranial transcranial Doppler ultrasound
assessment, as soon as possible, after onset of symptoms.
An MI was defined by the presence of two of the
following three criteria: specific cardiac enzymes (Troponin
I) more than twice the upper limit of normal; history of
chest discomfort for at least 30 min; or the development of
specific abnormalities (e.g., Q waves and ST elevation) on
a 12-lead electrocardiograph.Figure 1 Median Time to Carotid Endarterectomy (CEA) inExclusion criteria
Patients with asymptomatic disease or symptomatic patients
referred from outside Leicestershire (i.e., not being referred
to the newLeicestershire TIA service directly) were excluded.
Data collection
Datawas collected prospectively by a single investigator (MS)
through ‘direct face-to-face’ contact with patients, and
through analysis of documentation in clinical case notes and
by discussionwith the admitting consultant vascular surgeon.
Statistical analysis was performed using Statistical
Package for Social Sciences (SPSS) (v16).
Results
Between 1 October 2008 and 15 June 2010, 203 patients
underwent CEA in the Leicester Vascular Surgery Unit. In
total, 94 patients were excluded from the study due to being
asymptomatic (nZ 41) or referred from outside of Leices-
tershire that is, not referred to the new TIA service directly
(nZ 53).
As many as 109 symptomatic patients from Leicestershire
underwent a CEA and were included into the study. Twenty-
seven presented with a minor stroke (five with residual
neurological deficit), 74 with a TIA and eight with Amaurosis
fugax (Fig. 1). Fig. 1 also details themedian times from onset
of the index event to surgery and from the date of referral to
surgery. Overall, the median delay from index symptom to
CEAwas 9 days (95% confidence interval (CI) 7.5e10.5),while
the median delay from referral to surgery was 4 days (95% CI
3e5). There was no significant difference in delay to CEA
depending onmode of presentation (stroke, TIA, etc.). Fig. 2Relation to Timing of Index Event and Timing of Referral.
Figure 2 Cumulative delay (days) from date of referral to
undergoing Carotid Endarterectomy (CEA).
Table 2 Time from date of referral to surgery.
Time from referral
to surgery
Number of
patients treated
(total nZ 109)
Under 48 h 21 (19.2%)
3e7 Days 64 (58.7%)
8e14 Days 13 (11.9%)
>14 Days 11 (10%)
Table 3 Reasons for delay for patients undergoing CEA
>14 days after index event.
Reason NZ
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surgery from three consecutive time periods. The curves for
2006 and 2007 represent the effect of a surgeon with an
interest in carotid disease trying to make modifications in
practice to speed up treatment.10 As can be seen, this had
little impact in 2007. However, following the total reconfi-
guration of services in 2008, there was a dramatic reduction
in the delay from referral to surgery (90% patients operated
on within 14 days of referral). The mean length of hospital
stay pre-operatively was 2 days (range 0e12) following
introduction of the reconfigured service, comparedwith only
1 day before the service was introduced.
Tables 1 and 2 present the delays to surgery in greater
detail. Overall, 78% of patients underwent CEA within 14
days of the index event (Table 1), while 90% were treated
within 14 days of referral to the vascular team (Table 2).
This compares to only 11% and 21% of patients being treated
within 14 days of referral in 2006 and 2007, respectively.10
Only two patients underwent surgery within 48 h of the
index event, but 44% underwent CEA within 7 days of the
index event.
Table 3 presents the reasons for delay for the 25 patients,
who underwent CEAmore than 14 days after the index event.
Tables 4, 5 and 6 summarises the procedural risks,
stratified for mode of presentation, timing to surgery and
whether the patient had recurrent events after admission
to the vascular unit. Overall, there were no deaths within
30 days, but two patients suffered a stroke (1.83%) and one
patient suffered an MI (0.92%). One patient, who suffered
a perioperative stroke, was transferred to the VascularTable 1 Delay to surgery in relation to timing from index
event.
Time from index
event to surgery
Number of
patients treated
(total nZ 109)
Under 48 h 2 (1.8%)
3e7 Days 45 (41.3%)
8e14 Days 37 (33.9%)
>14 Days 25 (22.9%)Surgery Unit having suffered a Rankin 3 stroke. He then had
recurrent TIAs following admission and had spontaneous
embolisation during TCD monitoring. After a review of his
case, we proceeded to CEA. He suffered an intra-operative
stroke, it having not been possible to insert a shunt during
the procedure. It is assumed he extended the ischaemic
penumbra around his infarct. The second patient suffered
a non-disabling embolic stroke in the contralateral hemi-
sphere on day 24 after surgery. This patient had also
undergone CEA within 7 days of his index event (TIA).
Patients presenting with a stroke had a non-significantly
increased risk of post-operative death/stroke (3.7%) as
compared with 1.2% in patients presenting with a TIA or
Amaurosis fugax. Similarly, while both post-operative
strokes occurred in the 47 patients undergoing CEA within 7
days of the index event, this was not statistically signifi-
cantly higher than the 0% in 37 patients undergoing CEA
between 8 and 14 days and in the 25 patients undergoing
CEA after >14 days had elapsed. In addition, patients who
suffered recurrent events following transfer from the TIA
clinic incurred a 7.7% risk of death/stroke (1/13), but this
was not significantly higher than the 1% observed in 96
patients with no recurrent neurological events prior to
surgery.
Discussion
The timing of CEA for symptomatic carotid artery disease
remains an important benchmark for secondary stroke
prevention. The landmarkevidence for intervening inpatients
with extracranial symptomatic carotid artery disease cameDelay in presentation 9
Patient under OP review e
clinical status changed
from asymptomatic to
symptomatic
7
Unfit for anaesthesia due to
URTI
2
No surgeon available 1
Delay in transfer from stroke
unit
3
Delay in referral 2
Patient cancelled/refused
operation
1
Table 4 30-day death and stroke rate after CEA for symptomatic subgroups.
Presentation Death Ipsilateral
CVA
Contralateral
CVA
Any CVA Any Death/
CVA
MI
Stroke with residual deficit
(nZ 22)
0 1 (4.55%) 0 0 1 (4.55%) 0
Stroke without residual deficit
(nZ 5)
0 0 0 0 0 0
All Strokes (nZ 27) 0 1 (3.7%) 0 1 (3.7%)
TIA (nZ 74) 0 0 1 (1.35%) 1 (1.35%) 1 (1.35%) 1 (1.35%)
TIA/AFx (nZ 82) 0 0 1 (1.22%) 1 (1.22%) 1 (1.22%) 1 (1.22%)
All Symptomatic (nZ 109) 0 1 (0.92%) 1 (0.92%) 2 (1.83%) 2 (1.83%) 1 (0.92%)
226 M.K. Salem et al.from The European Carotid Surgery trial (ECST)16 and The
North American Symptomatic Carotid Endarterectomy Trial
(NASCET),17 which demonstrated benefit for treating patients
who reported carotid territory symptoms in the preceding 6
months and who had a NASCET 50e99% stenosis of the ipsi-
lateral carotid artery (ECST 70e99%).
The impetus for undertaking more rapid intervention
came from two recently published meta-analyses by Giles
and Wu.1,18 These meta-analyses showed that the risk of
stroke after a TIA was highest in the first 7 days. This, and
other natural history studies, has driven the move towards
expedited intervention as recommended by the latest
European Vascular Society, NICE and The UK National Stroke
Strategy guidelines.5e7
Conventional teaching has, however, taught that the risk
of stroke after a TIA is only about 1e2% at 7 days and 2e4%
at 28 days. The meta-analyses by Giles and Wu1,18 (which
were based on natural history studies that used ‘face-to-
face’ follow-up of the entire population of TIA patients)
demonstrated that, at 48 h, the risk of stroke increased to
6.7%, and was 10% at 7 days. This represents a fourfold
increase in the early risk of stroke after a patient presented
with index TIA.
Since the service reconfiguration, the workload of the
Vascular Surgery Unit has increased. To balance the need to
see patients urgently and have the service capabilities to
meet the demand, the urgency with which patients are
referred and then seen is now based upon the ABCD2 scoring
system. Ensuring that patients who have an ABCD2 score of
greater than 4 are assessed on the same (or next) day in the
rapid-access TIA clinic remains an important step in triaging
high-risk patients. This ABCD2 is a validated scoring system
for assessing the risk of early recurrent stroke after pre-
sentingwith a TIAorminor stroke.19 The scoring systembased
on five independent clinical variables: Age (>60 years scores
1), Blood pressure (systolic BP >140 mmHg or diastolic BP
>90mmHg scores 1), Clinical Symptoms (unilateral weaknessTable 5 30-day death and stroke rate after CEA in relation to
Delay Death Ipsilateral CVA C
Index symptom to CEA (1e7
days) (nZ 47)
0 1 (2.13%) 1
Index symptom to CEA (8e14
days) (nZ 37)
0 0 0
Index symptom to CEA (>14
days) (nZ 25)
0 0 0scores 2, speech impairment without weakness scores 1),
Duration of symptoms (duration >60 min scores 2, duration
10e59 min scores 1) and presence ofDiabetes (scores 1). This
gives a total score between 0 and 7. Studies have shown that
patients, who presentwith a score of 0e1, have a 1% and 1.2%
risk of stroke at 48 h and 7 days, respectively. Those with
a score of between 4 and 5 have a stroke risk of 4.1% and 5.9%
at 48 h and 7 days, respectively, while a score of between 6
and 7 predicts a stroke risk of 8.1% at 48 h and 12% at 7 days,
respectively. A parallel study by Giles et al.1 also demon-
strated similarly high risks of recurrent stroke in patients
presenting with a minor stroke. Our cohort of patients
included both high- and low-risk ABCD2 patients. No signifi-
cant difference in outcome was seen between high- and low-
risk ABCD2 patients, though this may be due to the small
number of patients with a recorded complication.
All the above natural history studies focussed on TIA
patients, irrespective of the extent of carotid disease. A
recent single-centre study20 evaluated the hyperacute risk
of stroke after TIA in patients with a carotid artery stenosis
of 50e99%. They observed that in patients with 50e99%
stenoses, the risk of stroke was 17% at 72 h, 22% at 7 days
and 25% at 14 days. It was also observed that patients with
a 70e99% stenosis had a significantly higher risk of stroke
than those with 50e69% stenosis.
However, while there may be good epidemiological
reasons for intervening early, surgeons remain concerned
that this will lead to significant increases in procedural
risks,8,9 despite the publication of studies suggesting that
this is not always likely to be the case. Results from the
Carotid Endarterectomy Trialists Collaboration (CETC)3
study demonstrated no significant difference in the proce-
dural risk in the early period, although patients presenting
with symptoms within 48 h or with crescendo TIAs were
excluded from the analysis. The 30-day death and stroke rate
following CEA in published series where patients presented
with crescendo TIAs or a non-disabling stroke and thentiming of index event.
ontralateral CVA Any CVA Any Death/CVA MI
(2.13%) 2 (4.26%) 2 (4.26%) 0
0 0 1 (2.7%)
0 0 0
Table 6 30-day death and stroke rate after CEA in patients presenting with recurrent events pre-operatively.
Death Ipsilateral CVA Contralateral CVA Any CVA Any Death/CVA MI
>1 event after admission
to vascular unit
(nZ 13)
0 1 (7.69%) 0 1 (7.69%) 1 (7.69%) 0
No further events after
index event(nZ 96)
0 0 1 (1.04%) 1 (1.04%) 1 (1.04%) 1 (1.04%)
Rapid Access Carotid Endarterectomy e Results from a Single-centre Study 227underwent CEAwithin 14 days found that the procedural risk
was less than 8% with a low risk of haemorrhagic trans-
formation from an ischaemic infarct.21e27 This level of
procedural riskmay be seen by some to be too high; however,
further analysis of the CETC data has allowed researchers to
model the number of strokes prevented per 1000 CEAs at 5
years in relation to the procedural risk and delay to surgery.
The evidence from this analysis suggests that surgical inter-
vention within 14 days with a procedural risk of less than 10%
would still preventmore strokes at 5 years than if surgerywas
delayed by 4 or more weeks and then performed with
a procedural risk of 0%.3
There are, however, a number of logistical issues that
still need to be addressed to deliver optimal service. In the
past, patients were admitted either on the day before
surgery, or on the morning of the procedure. Following our
service reconfiguration, the mean delay from admission to
surgery increased to 2 days (0e12). There were several
reasons for this (currently the subject of an ongoing audit)
including poor control of hypertension, admission over the
weekend or other untreated medical co-morbidities. In
addition, it has been our experience that the prevalence of
severe post-operative hypertension has increased in
patients undergoing expedited surgery, probably reflecting
the greater prevalence of patients with poorly controlled
hypertension pre-operatively. However, this has not caused
an increase in post-operative complications, probably
because the unit has written guidelines in all clinical areas
for dealing with hypertension as soon as it develops.
In conclusion, and contrary to the intuitive beliefs ofmany
surgeons, this study has shown that there has been no
significant increase in the procedural risk in symptomatic
patients undergoing expeditedCEA in thehyperacuteperiod.
This may, of course, be put down to chance (due to relatively
small numbers), but it is more likely to be due to the unit’s
policy of rapid implementation of the best medical treat-
ment in the TIA clinic, dual anti-platelet therapy immedi-
ately prior to surgery, intra-operative TCD monitoring,
completion angioscopy and rigorously enforced guidelines
for managing post-operative hypertension. Future studies
will ascertain whether these low risks can be maintained.
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